Search

Search Constraints

You searched for: Author/Creator Östlund, Ollie

Search Results

1. Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease. (15th October 2017)

2. Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction. Issue 6 (1st September 2019)

3. Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction. Issue 6 (September 2019)

4. Bivalirudin Versus Heparin Monotherapy in ST-Segment–Elevation Myocardial Infarction. (December 2021)

5. Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI). Issue 2 (13th December 2022)

7. Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease. (6th January 2020)

8. Impact of thrombus aspiration during ST-Elevation Myocardial Infarction: a six month composite endpoint and risk of stroke analyses of the TASTE trial. Issue 1 (December 2016)

9. Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. Issue 10 (24th October 2017)

10. Lipoprotein‐Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease. Issue 6 (21st June 2016)